Doxycycline-Regulated 3T3-L1 Preadipocyte Cell Line with Inducible, Stable Expression of Adenoviral E4orf1 Gene: A Cell Model to Study Insulin-Independent Glucose Disposal
Impaired glycemic control and excessive adiposity are major risk factors for Type 2 Diabetes mellitus. In rodent models, Ad36, a human adenovirus, improves glycemic control, independent of dietary fat intake or adiposity. It is impractical to use Ad36 for therapeutic action. Instead, we identified that E4orf1 protein of Ad36, mediates its anti-hyperglycemic action independent of insulin signaling. To further evaluate the therapeutic potential of E4orf1 to improve glycemic control, we established a stable 3T3-L1 cell system in which E4orf1 expression can be regulated. The development and characterization of this cell line is described here. Full-length adenoviral-36 E4orf1 cDNA obtained by PCR was cloned into a tetracycline responsive element containing vector (pTRE-Tight-E4orf1). Upon screening dozens of pTRE-Tight-E4orf1 clones, we identified the one with the highest expression of E4orf1 in response to doxycycline treatment. Furthermore, using this inducible system we characterized the ability of E4orf1 to improve glucose disposal in a time dependent manner. This stable cell line offers a valuable resource to carefully study the novel signaling pathways E4orf1 uses to enhance cellular glucose disposal independent of insulin.
References
[1]
Pessin JE, Saltiel AR (2000) Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106: 165–169.
[2]
Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106: 171–176.
[3]
Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799–806.
[4]
Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, et al. (2011) A Template to Improve Glycemic Control without Reducing Adiposity or Dietary Fat. Am J Physiol Endocrinol Metab 300: E779–789.
[5]
Krishnapuram R, Kirk-Ballard H, Dhurandhar EJ, Dubuisson O, Messier V, et al.. (2012) Insulin Receptor-independent Up-regulation of Cellular Glucose Uptake International Journal of Obesity In press.
[6]
Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, et al. (2011) E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One 6: e23394.
[7]
Dhurandhar EJ, Krishnapuram R, Hegde V, Dubuisson O, Tao R, et al. (2012) E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. PloS one 7: e47813.
[8]
Yarranton GT (1992) Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 3: 506–511.
[9]
Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, et al. (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A 85: 1204–1208.
[10]
Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547–5551.
[11]
Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766–1769.
[12]
Ewald D, Li M, Efrat S, Auer G, Wall RJ, et al. (1996) Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384–1386.
[13]
Thomas DD, Donnelly CA, Wood RJ, Alphey LS (2000) Insect population control using a dominant, repressible, lethal genetic system. Science 287: 2474–2476.
[14]
Iida A, Chen ST, Friedmann T, Yee JK (1996) Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol 70: 6054–6059.
[15]
Rogers PM MN, Rathod MA, Dubuisson O, Wang ZQ, Dasuri K, Babin S, Gupta A, Markward N, Cefalu WT, Dhurandhar NV (2008) Metabolically Favorable Remodeling of Human Adipose Tissue by Human Adenovirus Ad-36 Diabetes. 57: 2321–2331.
[16]
Rogers PM, Fusinski KA, Rathod MA, Loiler SA, Pasarica M, et al. (2008) Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond) 32: 397–406.
[17]
Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, et al. (2011) Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 300: E779–789.
[18]
Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, et al. (2011) E4orf1: A Novel Ligand that Improves Glucose Disposal in Cell Culture. PLoS ONE 6(8): e23394.
[19]
Pasarica M, Shin AC, Yu M, Ou Yang HM, Rathod M, et al. (2006) Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 14: 1905–1913.
[20]
Lee SS, Weiss RS, Javier RT (1997) Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94: 6670–6675.
[21]
Javier R, Raska K Jr, Shenk T (1992) Requirement for the adenovirus type 9 E4 region in production of mammary tumors. Science 257: 1267–1271.
[22]
Seandel M, Butler JM, Kobayashi H, Hooper AT, White IA, et al. (2008) Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proc Natl Acad Sci U S A 105: 19288–19293.
[23]
Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, et al. (2007) Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond) 31: 78–86.
[24]
Dhurandhar N (2012) Insulin sparing action of adenovirus 36 and its E4orf protein. Journal of Diabetes and Its Complications In press
[25]
Frese KK, Latorre IJ, Chung SH, Caruana G, Bernstein A, et al. (2006) Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor. Embo J 25: 1406–1417.
[26]
Frese KK, Lee SS, Thomas DL, Latorre IJ, Weiss RS, et al. (2003) Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 22: 710–721.
